Trinity Biotech PE Ratio 2006-2020 | TRIB

Current and historical p/e ratio for Trinity Biotech (TRIB) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Trinity Biotech PE ratio as of July 03, 2020 is 0.00.
Trinity Biotech PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-02 2.29 0.00
2020-03-31 1.10 $-0.18 0.00
2019-12-31 1.03 $-0.15 0.00
2019-09-30 1.21 $-1.07 0.00
2019-06-30 1.65 $-1.08 0.00
2019-03-31 2.85 $-0.87 0.00
2018-12-31 2.29 $-0.84 0.00
2018-09-30 4.00 $-1.52 0.00
2018-06-30 5.00 $-1.53 0.00
2018-03-31 5.15 $-1.52 0.00
2017-12-31 5.10 $-1.49 0.00
2017-09-30 5.61 $-3.62 0.00
2017-06-30 6.00 $-3.66 0.00
2017-03-31 5.96 $-3.61 0.00
2016-12-31 6.92 $-3.72 0.00
2016-09-30 13.22 $0.11 120.18
2016-06-30 11.34 $0.66 17.18
2016-03-31 11.66 $0.67 17.40
2015-12-31 11.76 $0.90 13.07
2015-09-30 11.44 $0.98 11.67
2015-06-30 18.06 $0.63 28.67
2015-03-31 19.02 $0.71 26.78
2014-12-31 17.30 $0.72 24.02
2014-09-30 18.05 $0.73 24.72
2014-06-30 22.75 $0.42 54.17
2014-03-31 23.72 $0.41 57.85
2013-12-31 24.61 $0.41 60.02
2013-09-30 21.30 $0.42 50.71
2013-06-30 16.49 $0.75 21.99
2013-03-31 16.33 $0.77 21.21
2012-12-31 13.95 $0.78 17.89
2012-09-30 12.16 $0.76 16.00
2012-06-30 11.61 $0.74 15.69
2012-03-31 10.19 $0.72 14.15
2011-12-31 9.72 $0.70 13.89
2011-09-30 8.75 $0.69 12.68
2011-06-30 9.49 $0.65 14.60
2011-03-31 8.87 $2.88 3.08
2010-12-31 8.33 $2.86 2.91
2010-09-30 5.98 $2.84 2.11
2010-06-30 5.75 $2.84 2.02
2010-03-31 5.15 $0.58 8.88
2009-12-31 3.82 $0.55 6.94
2009-09-30 3.73 $-3.52 0.00
2009-06-30 4.18 $-3.60 0.00
2009-03-31 1.65 $-3.67 0.00
2008-12-31 1.51 $-3.73 0.00
2008-09-30 2.67 $-1.96 0.00
2008-06-30 3.65 $-2.02 0.00
2008-03-31 4.34 $-1.95 0.00
2007-12-31 6.44 $-1.86 0.00
2007-09-30 9.93 $0.38 26.12
2007-06-30 10.97 $0.52 21.09
2007-03-31 8.58 $0.26 33.02
2006-12-31 8.10 $0.19 42.65
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.055B $0.090B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Boston Scientific (BSX) United States $49.509B 23.28
Baxter (BAX) United States $44.233B 27.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.94
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 35.54
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 153.85
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.51
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.46
Owens & Minor (OMI) United States $0.464B 12.27
Repro-Med Systems (KRMD) United States $0.394B 302.33
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
HEXO (HEXO) $0.311B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
InfuSystems Holdings (INFU) United States $0.213B 117.89
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Myomo (MYO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00